MX2014005153A - Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor. - Google Patents

Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.

Info

Publication number
MX2014005153A
MX2014005153A MX2014005153A MX2014005153A MX2014005153A MX 2014005153 A MX2014005153 A MX 2014005153A MX 2014005153 A MX2014005153 A MX 2014005153A MX 2014005153 A MX2014005153 A MX 2014005153A MX 2014005153 A MX2014005153 A MX 2014005153A
Authority
MX
Mexico
Prior art keywords
pain
pharmaceutical composition
tramadol hydrochloride
ketorolac tromethamine
production method
Prior art date
Application number
MX2014005153A
Other languages
English (en)
Inventor
Oliver Daniel Walls Flores
Ramón Rodríguez Hernández
Eduardo Barrena Hernández
Original Assignee
Liomont S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54359445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014005153(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liomont S A De C V Lab filed Critical Liomont S A De C V Lab
Priority to MX2014005153A priority Critical patent/MX2014005153A/es
Priority to PCT/IB2015/053098 priority patent/WO2015166419A2/es
Publication of MX2014005153A publication Critical patent/MX2014005153A/es
Priority to CL2016002656A priority patent/CL2016002656A1/es
Priority to SV2016005309A priority patent/SV2016005309A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición farmacéutica oral de la combinación de ketrolaco trometamina / clorhidrato de tramadol para el tratamiento de alopatías relacionadas con el dolor (de moderado a severo), analgésico, antiinflamatorio, fiebre o antipirética, para su administración oral y en específico como una tableta sublingual.
MX2014005153A 2014-04-29 2014-04-29 Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor. MX2014005153A (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
MX2014005153A MX2014005153A (es) 2014-04-29 2014-04-29 Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.
PCT/IB2015/053098 WO2015166419A2 (es) 2014-04-29 2015-04-29 Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor
CL2016002656A CL2016002656A1 (es) 2014-04-29 2016-10-19 Proceso de obtención y composición farmacéutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.
SV2016005309A SV2016005309A (es) 2014-04-29 2016-10-28 Proceso de obtenciã“n y composiciã“n farmacã‰utica para de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2014005153A MX2014005153A (es) 2014-04-29 2014-04-29 Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.

Publications (1)

Publication Number Publication Date
MX2014005153A true MX2014005153A (es) 2015-10-28

Family

ID=54359445

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014005153A MX2014005153A (es) 2014-04-29 2014-04-29 Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.

Country Status (4)

Country Link
CL (1) CL2016002656A1 (es)
MX (1) MX2014005153A (es)
SV (1) SV2016005309A (es)
WO (1) WO2015166419A2 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2607661C1 (ru) * 2015-11-30 2017-01-10 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) Ректальные суппозитории, обладающие болеутоляющим действием
WO2019143234A1 (es) 2018-01-22 2019-07-25 AMÉZCUA AMÉZCUA, Federico Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco trometamina y clorhidrato de tramadol

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018003456A (es) 2017-12-21 2019-09-06 Gruenenthal Gmbh Combinacion farmaceutica en la forma de comprimidos en bicapa que comprende ketorolaco trometamina y tramadol clorhidrato, y su uso para el tratamiento del dolor.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007003948A (es) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2607661C1 (ru) * 2015-11-30 2017-01-10 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) Ректальные суппозитории, обладающие болеутоляющим действием
WO2019143234A1 (es) 2018-01-22 2019-07-25 AMÉZCUA AMÉZCUA, Federico Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco trometamina y clorhidrato de tramadol

Also Published As

Publication number Publication date
SV2016005309A (es) 2017-05-15
WO2015166419A3 (es) 2016-01-07
WO2015166419A2 (es) 2015-11-05
CL2016002656A1 (es) 2017-02-17

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
PH12018502251A1 (en) Formulations of an lsd1 inhibitor
MY196173A (en) Cot Modulators And Methods Of Use Thereof
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
ZA202105976B (en) Pharmaceutical dosage form for application to mucous membranes and methods for producing same
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
MX2017015137A (es) Composicion farmaceutica oral de dosis diaria de isotretinoin.
EP4406969A3 (en) Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients
NZ735777A (en) Methods and compositions to inhibit symptoms associated with veisalgia
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX2014005153A (es) Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.
MX2017015322A (es) Composicion farmaceutica oral de isotretinoin.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PH12020500045A1 (en) Novel composition of enzalutamide oral dosage form and method of manufacturing thereof
WO2019132729A3 (ru) Фармацевтические композиции на основе ментилового эфира индометацина и его применение
MX2014005152A (es) Composicion farmaceutica para el tratamiento de alopatias relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol.
IN2013MU03428A (es)
TW201611830A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof
MX357376B (es) Composicion farmaceutica para uso en inflamacion y dolor.
PH12020500472A1 (en) Autotaxin inhibitor compounds
MX2016010919A (es) 4-bencilsulfonil-2-butenonitrilo.
MX2014013240A (es) Composicion farmaceutica para el tratamiento de la disfuncion erectil a base de un farmaco inhibidor de la enzima pde-5 (fosfodiesterasa tipo 5) en tabletas.